The trouble began on March 17, 2026, when TruBridge filed a notification of late filing, citing a need to address errors in previously issued financial statements. Management identified discrepancies dating back to 2023, specifically affecting revenue recognition, contract costs, and stock-based compensation. These accounting failures forced the company to initiate revisions to its consolidated financial statements for both 2023 and 2024, as well as its quarterly reports from 2025.
Investors Scrutinize TruBridge After Financial Reporting Errors
The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. following revelations that the healthcare technology company issued misleading business information. The inquiry stems from the company's inability to file its 2025 annual report, which triggered a sharp decline in share value and exposed systemic accounting discrepancies.
Investors reacted immediately to the disclosure, sending TruBridge stock plummeting by 10.5% to close at $15.75 per share that same day. Rosen Law is now seeking to represent shareholders in a potential class action to recover losses incurred from the alleged misinformation. Those who held shares during the relevant period may participate in the case through a contingency fee arrangement, which requires no out-of-pocket costs for participants. Interested parties are encouraged to contact Phillip Kim at the firm to discuss their legal standing.
Comments (0)
No comments yet. Be the first!